Drug Profile


Alternative Names: 4-MP; Antizol; Fomepizole; Fomepizole Intravenous Infusion 1.5g "Takeda"

Latest Information Update: 25 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer AFT Pharmaceuticals; Endo International; Jazz Pharmaceuticals plc; Takeda
  • Class Antidotes; Pyrazoles; Small molecules
  • Mechanism of Action Alcohol dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Methanol poisoning; Ethylene glycol poisoning
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Ethylene glycol poisoning; Methanol poisoning

Most Recent Events

  • 24 Apr 2017 Launched for Ethylene Glycol poisoning in Australia (IV)
  • 24 Apr 2017 Launched for Methanol poisoning in Australia (IV)
  • 27 Jan 2015 Launched for Ethylene Glycol poisoning in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top